Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics
Journal of Chemical Information and Modeling · 2025
DOI: 10.1021/acs.jcim.5c00601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2025. Verfasst von Adriana Coricello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, Italy. Hauptthemen laut MEDLINE: Muscarinic Antagonists, Receptor, Muscarinic M3, Receptor, Muscarinic M2, Tiotropium Bromide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
Ligand-target dissociation rates (koff) strongly correlate with efficacy and safety profiles, as well as with the therapeutic effect of drugs. As a prototypical example, muscarinic receptor antagonists used as bronchodilators show similar affinity profiles toward the muscarinic M3 receptors (M3R) and M2 receptors (M2R), whereas their kinetic selectivity toward M3R avoids the adverse effects that a prolonged inhibition of M2R would induce at the cardiac level. Previous studies on the dissociation kinetics of human M3R showed that the residence time and binding affinity of muscarinic antagonists are deeply affected by the presence of specific mutations. The aim of our work was to reproduce the rankings of these experimental kinetic rates through an approach based on the application of adiabatic-bias molecular dynamics (ABMD) simulations using Path Collective Variables (PCVs), PCV-ABMD. Employing this methodology, we simulated the translocation of tiotropium, a long-acting bronchodilator targeting M3R, from the orthosteric site to the extracellular vestibule, without considering the whole unbinding process. The estimated times necessary for translocation displayed a strong correlation with the experimental pkoff values. Moreover, a thorough analysis of protein-ligand contacts provided deeper insights into the mechanism of unbinding of muscarinic antagonists. The newly described PCV-ABMD protocol captured relevant metastable states and offered a reliable approach for the prediction of kinetic selectivity in sets of mutants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Sciences, Università degli Studi di Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, Italy.
- OMass Therapeutics Ltd., Building 4000, John Smith Dr, Oxford Business Park, ARC, OX4 2GX Oxford, U.K.
- Department of Pharmacy, University of Birmingham, Edgbaston, B15 2TT Birmingham, U.K.
ORCID-Profile: Adriana Coricello, Anna Lisa Chiaravalle, Maria Musgaard, Gian Marco Elisi, Giovanni Bottegoni
Förderung
- Ministero dell'Università e della Ricerca
Zitieren
APA
Coricello, A., Chiaravalle, A. L., Musgaard, M., Tehan, B. G., Elisi, G. M., & Bottegoni, G. (2025). Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c00601
Vancouver
Coricello A, Chiaravalle AL, Musgaard M, Tehan BG, Elisi GM, Bottegoni G. Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics. Journal of Chemical Information and Modeling. 2025. doi:10.1021/acs.jcim.5c00601
BibTeX
@article{Coricello2025,
author = {Coricello, Adriana and Chiaravalle, Anna Lisa and Musgaard, Maria and Tehan, Benjamin Gerald and Elisi, Gian Marco and Bottegoni, Giovanni},
title = {Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
doi = {10.1021/acs.jcim.5c00601}
}
EUVIMED